ADMA vs CLOV
ADMA Biologics Inc (ADMA) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ADMA and CLOV stock pages for the full models.
Not investment advice.